David R Grosshans
M.D. Anderson Cancer Center · NRG Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David R Grosshans as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:07 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03750513 · LET Optimized IMPT in Treating Pediatric Patients With EpendymomaM.D. Anderson Cancer Center · recruiting · Anaplastic Ependymoma, Ependymoma · principal investigator
- Ph2NCT03180502 · Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaNRG Oncology · active not recruiting · Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Characterization of the cellular mechanisms of radiation induced brain necrosis for clinical interventionR01CA255596 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2021 to 2025 · $174,887 awarded in 2025Same name and institution; not confirmed by an ID
- Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid modelR01CA256848 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2021 to 2025 · $412,116 awarded in 2025Same name and institution; not confirmed by an ID
- (PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiationR01CA208535 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2016 to 2020 · $469,904 awarded in 2020Same name and institution; not confirmed by an ID
- Mapping Proton RBE Variability Using Automated Biology and Monte Carlo TechniquesR21CA187484 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2014 to 2015 · $174,000 awarded in 2015Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Experimental Medicine ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2016 to 2026Named on NCT03750513
- Improving the Clinical Effectiveness and Understanding of the Biophysical BasisU19CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Theodore S Hong · fiscal years 2016 to 2018Named on NCT03750513
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2016 to 2026Named on NCT03180502
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ependymoma.